BPC-157 is widely researched for its potential to stimulate angiogenesis and cellular repair, offering hope for healing old, chronic injuries like persistent tendonitis, ligament tears, and non-union fractures. While initial clinical trials show promise, understanding the mechanisms and optimal usage is crucial.

The peptide’s regenerative properties are thought to activate specific healing pathways that may be dormant in long-standing scar tissue. This could potentially remodel and strengthen older tissue matrix, though scientific data is still accumulating.

Individual outcomes for chronic injury healing vary widely. Large-scale human clinical trials are ongoing to understand its long-term effectiveness on old versus new tissue. Consultation with a healthcare professional is strongly advised.